Trial Profile
Phase II Trial Of Pemetrexed Disodium And Gemcitabine In Advanced Urothelial Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary) ; Cyanocobalamin; Folic acid
- Indications Urogenital cancer
- Focus Therapeutic Use
- 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Aug 2005 New trial record.